Innate Pharma S.A.
IPHA
$2.07
$0.041.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.33% | -34.49% | -18.17% | -7.94% | 1.36% |
| Total Receivables | -90.46% | -91.28% | -96.69% | -96.28% | -72.35% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.65% | -28.38% | -53.60% | -47.80% | -11.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.84% | -45.93% | -85.87% | -84.10% | -7.75% |
| Total Current Assets | -36.18% | -41.67% | -45.74% | -38.96% | -24.18% |
|
|
|||||
| Total Current Assets | -36.18% | -41.67% | -45.74% | -38.96% | -24.18% |
| Net Property, Plant & Equipment | -5.52% | -13.64% | -23.95% | -14.44% | -22.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -87.07% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -41.63% | -46.65% | -12.82% | -1.92% | 118.51% |
| Total Assets | -32.76% | -38.54% | -40.62% | -33.20% | -25.30% |
|
|
|||||
| Total Accounts Payable | -43.00% | -47.90% | -13.32% | -2.48% | -12.96% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.67% | 0.24% | -8.71% | 2.70% | 64.26% |
| Total Finance Division Other Current Liabilities | -14.95% | -22.26% | -30.83% | -22.18% | -10.24% |
| Total Other Current Liabilities | -14.95% | -22.26% | -30.83% | -22.18% | -10.24% |
| Total Current Liabilities | -15.62% | -22.88% | -22.06% | -12.31% | -0.40% |
|
|
|||||
| Total Current Liabilities | -15.62% | -22.88% | -22.06% | -12.31% | -0.40% |
| Long-Term Debt | -25.53% | -31.93% | -32.12% | -23.63% | -25.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.91% | -7.74% | -72.16% | -68.68% | -68.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -23.77% | -30.32% | -16.53% | -6.10% | -16.67% |
| Total Liabilities | -21.58% | -28.32% | -22.34% | -12.63% | -14.70% |
|
|
|||||
| Common Stock & APIC | 15.66% | 5.72% | -4.68% | 7.24% | -0.66% |
| Retained Earnings | -23.56% | -12.94% | -7.42% | -20.85% | -8.02% |
| Treasury Stock & Other | 268.61% | 236.95% | -94.88% | -94.25% | -67.19% |
| Total Common Equity | -80.42% | -82.10% | -84.06% | -82.06% | -51.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.42% | -82.10% | -84.06% | -82.06% | -51.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.42% | -82.10% | -84.06% | -82.06% | -51.16% |
|
|
|||||